Skip to content

Prospective research for decreasing blood loss in Cesarean Section of Complete Placenta Previa

New Tourniquet Device for Hemorrhage Control at Cesarean Section of Complete Placenta Previa

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-11001545
Enrollment
Unknown
Registered
2011-08-18
Start date
2008-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Placenta Previa

Interventions

1:Tourniquet Device used in CS
2:normal CS

Sponsors

South-west Hosptil of Third Millitary Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: (1) gestation duration of at least 36 weeks and antepartum hemorrhage (gestational age was determined on the basis of the last menstrual period as confirmed by an ultrasound scan taken between the 14th and 20th week, and calculated in menstrual weeks); (2) trans-abdominal and trans-vaginal ultrasound examinations would therefore provide evidence that the internal cervical os is completely covered by placenta and at least part of the placenta is attached to the anterior wall of the uterus.

Exclusion criteria

Exclusion criteria: (1) gestation duration of at least 36 weeks and antepartum hemorrhage (gestational age was determined on the basis of the last menstrual period as confirmed by an ultrasound scan taken between the 14th and 20th week, and calculated in menstrual weeks); (2) trans-abdominal and trans-vaginal ultrasound examinations would therefore provide evidence that the internal cervical os is completely covered by placenta and at least part of the placenta is attached to the anterior wall of the uterus.

Design outcomes

Primary

MeasureTime frame
Propotion of patients accepted blood transfusion;Proportion of other rescue performances;Quantity of hemorrhag;

Secondary

MeasureTime frame
Blood gas analysis of umbilical artery;Involution of uterus;

Countries

China

Contacts

Public ContactChang Qing
hhtmmu@yahoo.com.cn+86 023 68765399

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026